Market Place
Sourcing Support
Microbot Medical To Showcase LIBERTY Endovascular Robotic System
14 Apr 2026 //
GLOBENEWSWIRE
Microbot Medical Starts Full Market Release Of LIBERTY
13 Apr 2026 //
GLOBENEWSWIRE
Emory Completes First Robotic Endovascular Procedure with LIBERTY
26 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical Bolsters LIBERTY Robotic System With ACCESS
24 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical To Attend Roth Conference
17 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical To Debut At Oppenheimer Healthcare Medtech
10 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical Aligns With Largest U.S. Medical Association
04 Mar 2026 //
PHARMIWEB
Microbot Medical Affirms Stability Amid Geopolitical Tensions
03 Mar 2026 //
GLOBENEWSWIRE
Tampa General First in Florida to Adopt LIBERTY Robotic System
24 Feb 2026 //
GLOBENEWSWIRE
Microbot Medical`s LIBERTY Endovascular Robotic System Showcased
19 Feb 2026 //
GLOBENEWSWIRE
Microbot`s LIBERTY Robotic System Shines at Vascular Conference
12 Feb 2026 //
GLOBENEWSWIRE
Microbot Medical To Showcase LIBERTY® Robotic System At Oncology
06 Feb 2026 //
PHARMIWEB
Microbot Medical Presents LIBERTY at the Oncology Conference
05 Feb 2026 //
GLOBENEWSWIRE
Microbot Medical Gains 2025 Momentum, Unveils Key 2026 Plans
12 Jan 2026 //
GLOBENEWSWIRE
Emory Hospital First to Adopt Microbot Medical`s LIBERTY System
26 Nov 2025 //
GLOBENEWSWIRE
Microbot Medical Begins Limited U.S. Market Release Of Liberty
05 Nov 2025 //
GLOBENEWSWIRE
Microbot Medical to Launch Liberty System at Oncology Meeting
16 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Secures US Logistics Partner For Liberty System
14 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Completes $92.2M Preferred Investment Options
07 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Secures Initial Patent In Japan, Expanding
01 Oct 2025 //
GLOBENEWSWIRE
Miocrbot Medical Ceo To Address FDA Clearance Of Liberty
23 Sep 2025 //
GLOBENEWSWIRE
Microbot Medical Closes 1st $92.2M Preferred Investment Exercise
16 Sep 2025 //
GLOBENEWSWIRE
Microbot Medical Announces $92.2M Preferred Investment Exercise
15 Sep 2025 //
GLOBENEWSWIRE
Microbot Showcases FDA-Cleared LIBERTY Robotic System at Event
09 Sep 2025 //
GLOBENEWSWIRE
Microbot Medical® Gets FDA Clearance for LIBERTY® Robotic System
08 Sep 2025 //
GLOBENEWSWIRE
Microbot Medical Gets US Patent for Expanded Market Applications
21 Aug 2025 //
PHARMAWEB
Microbot Medical Receives Patent for Expanded Market Applications
20 Aug 2025 //
GLOBENEWSWIRE
Microbot Medical Enhances Operational Capabilities
05 Aug 2025 //
GLOBENEWSWIRE
Microbot Medical® Appoints Christina Bailey as VP of Sales
22 Jul 2025 //
GLOBENEWSWIRE
Microbot Medical Leads Robotics Talk at Surgery Meeting
08 Jul 2025 //
GLOBENEWSWIRE
Microbot Medical® Added to the Russell Microcap® Index
30 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical strengthens global IP with new patent in China
17 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical Strengthens Commercial Capabilities for Q3 2025
09 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical Chosen for Russell Microcap® Index
05 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical® Adds Experienced Healthcare Officers to Leader
23 Apr 2025 //
GLOBENEWSWIRE
Microbot Clears Study Of Remote-Controlled Vascular Procedures
14 Apr 2025 //
FIERCE BIOTECH
Microbot Medical® Reports 100% Robotic Navigation Success
09 Apr 2025 //
GLOBENEWSWIRE
Microbot Medical to Present Data at SIR Annual Meeting
01 Apr 2025 //
GLOBENEWSWIRE
Microbot Hires Sales Executive To Lead US Liberty® Expansion
04 Mar 2025 //
GLOBENEWSWIRE
Robotic Telesurgery Data Accepted for Presentation at CRT Meeting
25 Feb 2025 //
GLOBENEWSWIRE
Microbot Medical Closes $13 Million Registered Direct Offering
11 Feb 2025 //
GLOBENEWSWIRE
Microbot Medical Announces $13M Registered Offering under Nasdaq
10 Feb 2025 //
GLOBENEWSWIRE
Microbot Medical Announce Abstract Acceptance at SIR Annual Meeting
04 Feb 2025 //
GLOBENEWSWIRE
Microbot Strengthens Team Ahead Of LIBERTY® Commercial Launch
21 Jan 2025 //
GLOBENEWSWIRE
Microbot Adds David J. Wilson To Board For Commercial Expansion
13 Jan 2025 //
GLOBENEWSWIRE
Microbot Medical Closes $8.6 Million Registered Direct Offering
10 Jan 2025 //
GLOBENEWSWIRE
Microbot Closes $8.6M Direct Offering Under Nasdaq Market Rules
08 Jan 2025 //
GLOBENEWSWIRE
Microbot Raises $11.8M Via Offering And ATM Facility
07 Jan 2025 //
GLOBENEWSWIRE
Microbot Closes $7M Offering Under Nasdaq Rules At-The-Market
06 Jan 2025 //
GLOBENEWSWIRE
Microbot Medical Achieves Milestones for LIBERTY® FDA Submission
30 Dec 2024 //
GLOBENEWSWIRE
Microbot Medical Announces FDA Submission for Liberty System
10 Dec 2024 //
GLOBENEWSWIRE
Microbot Medical CEO Discusses Endovascular Robotics on Benzinga
10 Dec 2024 //
GLOBENEWSWIRE
Microbot Medical Completes Trial Prepares For Liberty Launch
15 Oct 2024 //
GLOBENEWSWIRE
Microbot Medical Accelerates Patient Enrollment In Clinical Trial
30 Sep 2024 //
GLOBENEWSWIRE
Microbot Medical Reaches 50% Enrollment in LIBERTY Trial
17 Sep 2024 //
GLOBENEWSWIRE
Microbot Medical Signs Collaboration For LIBERTY® Robotic System
22 Aug 2024 //
GLOBENEWSWIRE
Microbot Medical Receives Quality Certification For Future Submissions
13 Aug 2024 //
GLOBENEWSWIRE
Microbot And Emory To Evaluate LIBERTY System`s Autonomous Capabilities
01 Aug 2024 //
GLOBENEWSWIRE
Microbot Medical Adds Memorial Sloan Kettering To Pivotal Clinical Trial
18 Jul 2024 //
GLOBENEWSWIRE
Microbot Medical Ramps Up Enrollment In Pivotal Human Clinical Trial
09 Jul 2024 //
GLOBENEWSWIRE
